|
National Stock Number(NSN): 6505-01-718-1707 (6505017181707, 017181707)
| NIIN: |
01-718-1707 |
Item Name: |
CHIKUNGUNYA VACCINE |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
Feb-15-2024 |
CRIT: |
X |
IIG: |
77777 |
| ISC: |
5 |
Date Standardized: |
Feb-15-2024 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-2025 |
PMIC: |
A |
FIIG: |
A23900 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
0 |
RPDMRC: |
5 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
1663546 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM249618 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC42515-0003-01 |
43FM1
|
VALNEVA USA, INC. |
H |
3 |
2 |
4 |
ZZ |
|
K |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
L |
|
M |
U |
1 |
A |
$252.59 |
EA |
|
C2201X- |
Oct-01-2025 |
H |
| DF |
SMS |
L |
|
M |
U |
1 |
F |
$252.59 |
EA |
|
------- |
Oct-01-2025 |
H |
| DM |
SMS |
Y |
Z |
M |
U |
1 |
M |
$252.59 |
EA |
|
1-B4--- |
Nov-01-2025 |
H |
| DN |
SMS |
L |
|
M |
U |
1 |
N |
$252.59 |
EA |
|
9B----- |
Oct-01-2025 |
H |
| DS |
SMS |
L |
|
M |
U |
1 |
I |
$252.59 |
EA |
|
------- |
Oct-01-2025 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DM |
V |
DISCONTINUED WITHOUT REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
CHIKUNGUNYA VACCINE, LIVE (IXCHIQ) SOLUTION, SINGLE-DOSE 0.5ML VIAL AND PREFILLED SYRINGE |
| FEAT |
SPECIAL FEATURES |
CHIKUNGUNYA VACCINE (IXCHIQ) IS A VACCINE INDICATED FOR THE PREVENTION OF DISEASE CAUSED BY CHIKUNGUNYA VIRUS (CHIKV) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER WHO ARE AT INCREASED RISK OF EXPOSURE TO CHIKV; THIS INDICATION IS APPROVED UNDER ACCELERATED APPROVAL BASED ON ANTI-CHIKV NEUTRALIZING ANTIBODY LEVELS (SEE CLINICAL STUDIES (14)); ADMINISTER A SINGLE DOSE OF IXCHIQ BY INTRAMUSCULAR INJECTION; AFTER RECONSTITUTION, A SINGLE DOSE OF IXCHIQ IS APPROXIMATELY 0.5 ML; IXCHIQ IS SUPPLIED IN A CARTON (NDC 42515-003-01) CONTAINING: ONE SINGLE-DOSE VIAL OF LYOPHILIZED ANTIGEN COMPONENT, LIVE (NDC 42515-004-01), ONE PREFILLED UNGRADUATED SYRINGE OF STERILE WATER DILUENT COMPONENT (NDC 42515-005-01), PACKAGED WITHOUT NEEDLES; STORE VIAL OF LYOPHILIZED ANTIGEN COMPONENT, LIVE, AND SYRINGE OF STERILE WATER DILUENT COMPONENT IN A REFRIGERATOR AT 2 C TO 8 C (35 F TO 46 F); STORE IN THE ORIGINAL CARTON TO PROTECT FROM LIGHT; SHELF LIFE IS 24 MONTHS; DO NOT FREEZE. |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
|
Feb-01-2024 |
3 |
Z |
|
|
AM|GX |
AM|BN|GX |
| N9BL |
|
Feb-01-2024 |
3 |
Z |
|
|
GX |
GH|GX |
| FSGM |
|
Feb-01-2024 |
3 |
Z |
|
|
GX|TT |
GX|SS|TT |
| Source: |
P |
Primary Inventory Control Activity (PICA) |
Status: |
H |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
|
| Lvl A Pkg Req: |
Z |
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
Z |
Unit Pack Weight: |
0.0 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.000 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
M |
Unpkg Item Dims: |
|
Spec Marking: |
ZZ |
| Supp Inst: |
APPLICABLE TO ALL MEDICAL |
| Container FSC: |
|
SPI Number: |
|
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
|
Pkg Design Activity: |
|
| Inter Container Qty: |
ZZZ |
Inter Container Code: |
ZZ |
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
5 |
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|